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Bisphosphonates (BP) are stable analogues of pyrophosphate with a P-C-P struc-
ture and 2 side chains attached to the carbon atom. Intravenous bisphosphonates 
are primarily used and effective in the management of cancer-related conditions in 
the context of solid tumors, such as breast cancer, prostate cancer, and lung cancer. 
Moreover bisphosphonates are subministred to patients with metabolic bone disease 
such as osteoporosis and Paget disease. Bisphosphonate-associated osteonecrosis of 
the jaws (BONJ) is a really complication of intravenous bisphosphonates therapy in 
patients with cancer. It is common knowledge that the jaws have a greater blood sup-
ply than other bones and a fasterbone turnover rate, related both to their daily activ-
ity and presence of teeth which mandates daily bone remodeling around the perio-
dontal ligament; moreover bisphosphonates toxicity to epithelial cells has been well 
documented. On this basis, the aim of this experimental study is to evaluate the path-
ological changes of the mandibular bone and oral mucosa in rat treated with bispho-
sphonates. In details we have analyzed, by immunoistochemical and scanning elec-
tron microscopic methods, biopsy of mandibular bone and of gingival mucosa in rat 
treated with bisphosphonates after 7, 15, 30, 45, 60 days of assumption of drugs and 
after 7 and 30 days from the end of the treatment. Our results show great area dem-
ineralization bone mixed to normal bone, moreover in the demineralization bone it’s 
possible to observe numerous micro lacunae. In the correspondence samples of gingi-
val epithelium we observe changes of histological structure and the disappearance of 
protein adhesion system cells to cells and cells to matrix. On this basis it is intriguing 
to speculate that the adverse effects of BP on oral epithelium may play a critical role 
in the initiation of BONJ an “outside-in” hypothesis.
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